While Wall Street analysts’ assessment of a publicly traded enterprise shouldn’t be considered the absolute truth, their collective voices and influence certainly force investors to pause for thought. That’s the present situation travel technology firm Expedia Group Inc EXPE finds itself in, ahead of next Thursday’s first-quarter earnings disclosure.
Not surprisingly, several analysts have weighed in on the matter, with many maintaining a Neutral or Equal-Weight rating. Even more telling, on April 28, experts at UBS and Piper Sandler reduced their price target on EXPE stock, with the former dropping expectations to $170 from $194, and the latter lowering it to $174 from $210. Also, on April 17, Morgan Stanley reduced its price target to $150 from $190.
During the midweek session, investors learned that the U.S. economy contracted in the first quarter of this year, representing the first negative growth reading since the second quarter of 2022. Naturally, the key catalyst…
Stay Ahead with Travel Trade Today — AI News That Matters
Get curated travel AI insights — choose the newsletters that matter to you.



































